AMRI files two brand-new patent infringement lawsuits AMRI announced today that it has filed two fresh patent infringement lawsuits in U.S. District Courtroom in New Jersey against Dr., Dr. And Sandoz, Inc.S. Patent #7 7,390,906.S. D’Ambra. In 2008 November, AMRI announced a settlement relating to two U.S.S. And Barr Laboratories, Inc. And Barr Laboratories, Inc. Through 2015, along with additional considerations.Financial results for the first one fourth of 2012: Adjusted net income of $672.4 million for the first quarter of 2012, in comparison to $582.5 million for the initial quarter of 2011. Adjusted cash-basis net gain per diluted common talk about of $0.77 for the first quarter of 2012, in comparison to adjusted cash-basis net income per diluted common share of $0.61 for the first quarter of 2011. Adjusted product and providers revenues from our Professional Diagnostics segment were $516.7 million in the first quarter of 2012, in comparison to adjusted net item and services revenue of $409.8 million in the first quarter of 2011.9 million of incremental net revenue when compared to first quarter of 2011. North American influenza sales decreased to $6.6 million for the initial quarter of 2012, from $19.5 million for the first quarter of 2011.